Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526454) titled 'Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tanta University
Condition:
Electroconvulsive Therapy
Intravenous Ketamine
Treatment-Resistant
Major Depressive Disorder
Intervention:
Drug: Electroconvulsive Therapy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 1, 2025
Target Sample Size: 70
Countries of Recruitment:
Egypt
To kn...